LIVINGSTON, N.J., June 10 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. , the recognized leader in advanced injection technologies, today announced that Unident AB, a leading European distributor of dental products to professional dental practitioners, has been granted exclusive rights to market, distribute and sell Milestone’s award-winning STA(TM) System in the Scandinavian countries of Denmark, Sweden, Norway and Iceland.
Unident AB, with an annual sales growth rate of 25%, is the fastest growing and third largest dental distributor in the Scandinavian market with direct operations in Sweden, Norway, Denmark and Iceland. The Company is focused on new innovations and technical solutions within dentistry. Unident AB represents, among other world leading suppliers, Schick Technologies, Geistlich Biomaterials, RTD and Discus Dental.
“Unident AB is widely recognized as a company that supplies best-of-class dental products that are capable of positively impacting dentists’ practices. As a trusted business partner and longstanding distributor of The Wand(R), Unident AB has consistently proven to be one of Milestone’s best performing distributors in the world. The addition of Unident as our exclusive distributor of the STA System further strengthens what Milestone views as a key strategic alliance in the European market place and will undoubtedly help us accelerate our global sales momentum. With Patterson Dental and Henry Schein now both marketing the STA System in North America, and Unident AB managing distribution in Scandinavia, their collective efforts should measurably impact Milestone’s ability to gain much greater sales traction as we progress through 2008,” stated Joe Martin, Chief Executive Officer of Milestone.
The state-of-the-art STA System is Milestone’s latest achievement in computer-controlled local anesthesia delivery (CCLAD) that makes the injection process more comfortable for both dentists and patients. Marketed for use by dental practitioners to painlessly administer all dental injections, the STA System is uniquely capable of administering “Single Tooth Anesthesia” into the Peridontal Intraligamentary (PDL) space, something never before possible using conventional techniques. In 2007, Milestone was granted CE Mark approval for the STA System, paving the way to begin marketing the instrument to dentists in African countries and other countries around the world that recognize the CE Mark approval process.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company’s IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System computer- controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone’s existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company’s web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of the Milestone’s ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
CONTACT: Dodi Handy, President and CEO of Elite Financial Communications
Group-Elite Media Group, +1-407-585-1080, mlss@efcg.net, for Milestone
Scientific Inc.
Web site: http://www.milesci.com/
